DNA damage induced by drugs such as ciprofloxacin promotes the formation of the RecA filament leading to auto-cleavage of LexA and allows expression of SOS genes, including the error-prone polymerases (such as DinB). RecA is also involved in recombination events. The SOS pathway plays a critical role in the acquisition of mutations that lead to the emergence of antibiotic resistant bacteria. [1, 2] . To date, the number of SOS inhibitors is extremely low. This work aims to select new agents able to inhibit the SOS response induced by ciprofloxacin. An Escherichia coli strain with integrated sulA::lacZ reporter was applied to screen a set of 33 natural products (plant extracts and isolated compounds). The effects of active compounds were confirmed by (i) flow cytometry (analysis of cell mass and DNA content); (ii) bacteriophage transduction; (iii) mutagenesis induced by ciprofloxacin (using a strain with inactive lac operons which could be made functional through recombination [3]); and DinB expression (DinB::lacZ reporter strain). The initial antimicrobial screening revealed 5 agents able to inhibit sulA expression induced by ciprofloxacin. Among them we decided to focus on the activity of an isolated compound: sinapic acid (SA). This molecule inhibited the expression of sulA by ciprofloxacin in a dose dependent way (maximum inhibition was 85.85% at 4 µg/mL). Ciprofloxacin induces an increase in the ratio of cell mass/DNA content which was prevented by SA (37% at 4 µg/mL). SA also significantly reduced the phage transduction mediated by recA (around 50%), as well as the mutagenesis and expression of DinB induced by ciprofloxacin. Our results indicate sinapic acid as a possible inhibitor of SOS response of E. coli induced by ciprofloxacin and may be used in the development of new therapies to help the combat of antimicrobial resistance.
